@LevBubis
 Toronto, Ontario
Joined January 2017
  • Tweets21
  • Following109
  • Followers118
1Media
A short history (14 slides) of adjuvant therapy for pancreatic cancer #TheAmylaseSchool #HiloAEG #UEGambassador #GItwitter @EurPancClub @YouppiePancreas @maloehr1 @lelecapurso #PancreaticCancer 👇👇👇
3
47
5
78
#GI22 📢Before the meeting gets rolling, I would like to present the abstracts I am keeping my eye👁️on My Top 10(ish) #PancreaticCancer abstracts and My Top 10 non-pancreatic abstracts
6
24
5
79
PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to preve… pubmed.ncbi.nlm.nih.gov/3417…

PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancrea...

The use of Hemopatch™ was not associated with a decreased incidence of clinically-significant POPF compared to historical rates. (NCT03410914).

pubmed.ncbi.nlm.nih.gov
1
6
7
Lev Bubis retweeted
ICES@ICESOntario23 Aug 2019
New @ICESOntario study led by @LevBubis & @alyson_mahar looked at patient-reported symptom severity among 22,650 cancer outpatients in the last 6 months of life sciencedirect.com/science/ar…
2
2
Congratulations @niv_vela on his GOLDEN STETHOSCOPE AWARD!! An Outstanding @uoftmedicine #medstudent in the Peters-Boyd Academy @Sunnybrook!! Great work presented @SocSurgOnc on costs/benefits of adjuvant therapy for #pancreascancer-should be published soon!
1
1
28
Our study in @AATSJournals looking at esophagectomy readmissions in Ontario: 1. No change in readmission rate over 13 yrs 2. Same at thoracic & non-thoracic centres 3. 18% readmitted at 'best' centre Not all readmissions are 'bad' doi.org/10.1016/j.jtcvs.2019… #tssmn #SoMe4Surgery
Vaibhav Gupta, MD, PhD@VGupta_MD29 Mar 2019
Rescue is a 🔑 part of high-volume / centre of excellence care. On a related point, readmission is a form of outpatient rescue. We need 🏨 leaders to recognise that many surgical readmissions are necessary, not indicators of ⬇️ quality! #tssmn @biniamkidaneMD @DrNCoburn
1
9
2
22
Important info on pt-reported symptom burden after #NET diagnosis now in @OncJournal. Frequent symptoms and burden persists over 5y. Now, need to use this data to ⬆️ early & longitudinal supportive care 🦓 @CNETSCanada Supported by @NANETS1 @IRSC_CIHR onlinelibrary.wiley.com/doi/… – at Québec, Canada
1
5
11
Incorporating Patient Preferences in Non-inferiority Trials: Our proposal to improve the clinical utility and interpretation of non-inferiority trials @JAMA_current @enenbee @tyler_chesney @UofTSurgery jamanetwork.com/journals/jam…
1
5
18
An assessment of 23,840 Stage I-III breast cancer patients shows high rates of symptom burden, especially in younger women, more advanced stage, lower income patients. Can we use this data to improve symptoms during treatment? authors.elsevier.com/a/1XNhN…
5
1
9
Cancer-related fatigue (CRF) is increasingly recognised as one of the most common and distressing side effects of cancer and its treatments. It has a negative impact on work, social... powerfulpatients.org/2017/08…
1
19
26
Individualized post-op management w/ e-health using patient reported outcomes, a RCT @TheLancet thelancet.com/journals/lance… thelancet.com/journals/lance…
14
4
35
Can we improve surgical outcomes by promoting exercise, nutrition, and lifestyle modifications prior to major operations? @Sunnybrook team has created a #prehab program for cancer patients @CancerCare_ON ncbi.nlm.nih.gov/pubmed/2986…
13
31
Lev Bubis retweeted
ASCO
@ASCO4 Jun 2018
Phase III trial: People with surgically removed pancreatic cancer who received mFOLFIRINOX chemo lived a median of 20 months longer than those who received gemcitabine bit.ly/2JcgHnh #ASCO18
4
89
27
134
PRODIGE 7 : HIPEC added to cytoreductive surgery for isolated CRC peritoneal mets does not improve OS and increases late post-op complications
9
9
Lev Bubis retweeted
NEJM
@NEJM3 Jun 2018
Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) nej.md/2JkWbEu #ASCO18
3
215
48
272
Immunoscore for the classification of #coloncancer: study provides a reliable estimate of the risk of recurrence in patients with colon cancer @sitcancer hubs.ly/H0c2fLc0
2
24
1
22
Congratulations to Yunni Jeong for her Best Presentation Award at the 2018 Korean Gastric Cancer Association meeting! @UofTSurgery @mygutfeelingca
1
4
1
17
Congratulations to @DrNCoburn! So very well-deserved! xitter.cf/ShadyAshamalla/status/…
1
Laura Davis from @DrNCoburn's team presenting research on province-wide cancer patient-reported outcomes data at CCO Research Day 2018! @ICESOntario @Sunnybrook #PROs #CancerResearch
1
5
Load more